In Brief: Aastrom Biosciences
Executive Summary
Aastrom Biosciences: Initial public offering will consist of 3 mil. common shares at $7 apiece. Cowen & Co. and J.P. Morgan will manage the IPO for the Ann Arbor, Michigan-based cell therapy company...